Advances in neoadjuvant therapy for colorectal cancer with liver metastases Journal Article


Authors: Pozzo, C.; Barone, C.; Kemeny, N. E.
Article Title: Advances in neoadjuvant therapy for colorectal cancer with liver metastases
Abstract: Metastatic colorectal cancer (CRC) is most frequently seen in the liver. Resection of metastases remains the treatment of choice; however, the majority of patients are ineligible for surgery due to unfavorable location, size, or number of metastases; insufficient liver reserve; or extrahepatic disease. The activity of irinotecan- and oxaliplatin-based regimens as first-line therapy has prompted the investigation of these agents as neoadjuvant therapy in patients with resectable and unresectable disease. Although studies suggest considerable promise for a neoadjuvant strategy in patients with unresectable liver metastases, the heterogeneity, small size, and retrospective nature of many of these studies precludes drawing firm clinical conclusions at this time, especially in patients with resectable disease. Therefore large, prospective trials that examine the impact of preoperative chemotherapy in patients with initially unresectable or resectable liver metastases are needed. These trials must include well-defined criteria for resectability and clear reporting of the extent of resection. © 2008 Elsevier Ltd. All rights reserved.
Keywords: cancer surgery; clinical trial; drug activity; review; cancer localization; bevacizumab; cisplatin; fluorouracil; placebo; monotherapy; clinical trials as topic; liver neoplasms; capecitabine; cancer adjuvant therapy; cancer patient; combined modality therapy; neoadjuvant therapy; chemotherapy; colorectal cancer; multiple cycle treatment; antineoplastic combined chemotherapy protocols; camptothecin; combination chemotherapy; dexamethasone; continuous infusion; cetuximab; irinotecan; panitumumab; colorectal neoplasms; liver metastasis; add on therapy; folinic acid; cancer size; epirubicin; hepatectomy; resection; inoperable cancer; preoperative treatment; oxaliplatin; floxuridine; organoplatinum compounds
Journal Title: Cancer Treatment Reviews
Volume: 34
Issue: 4
ISSN: 0305-7372
Publisher: Elsevier Inc.  
Date Published: 2008-06-01
Start Page: 293
End Page: 301
Language: English
DOI: 10.1016/j.ctrv.2008.01.004
PUBMED: 18291590
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 11" - "Export Date: 17 November 2011" - "CODEN: CTRED" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Kemeny
    543 Kemeny